Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2007; Volume 189, Supplement 653
The 86th Annual Meeting of The German Physiological Society
3/25/2007-3/28/2007
Hannover, Germany


THE DISEASE-ASSOCIATED PROTEINS CDR2 AND TRIM37 ARE REGULATED BY HIF PROLYL-4-HYDROXYLASE 1
Abstract number: O08-7

Kuppusamy1 B, Hofmann1 VS, Wenger1 RH, Camenisch1 G

1Institute of Physiology, University of Zurich

The hypoxia-inducible heterodimeric transcription factor HIF is the master regulator of the hypoxic response in eukaryotic cells. Prolyl-4-hydroxylase domain-containing (PHD1-3) and asparaginyl hydroxylase (FIH) enzymes regulate the stability and transcriptional activity of HIF-a subunits by oxygen-dependent hydroxylation of prolyl and asparaginyl residues, respectively. We asked whether these iron-dependent dioxygenases have alternative substrates other than HIF-a. By yeast two-hybrid screening, we have identified several PHD1 interacting proteins, including the onconeural antigen cerebellar degeneration-related 2 (Cdr2) protein and TRIM37, a member of the tripartite motif protein family. Cdr2 is associated with paraneoplastic syndromes in which neoplastic expression of Cdr2, especially in breast and ovarian cancer patients, triggers an autoimmune response that culminates in cerebellar degeneration. Mulibrey (Muscle-liver- brain-eye) nanism is a rare autosomal recessive growth disorder caused by mutations in TRIM37 that encodes for a RING finger ubiquitin E3 ligase. By transient transfection assays in HeLa cells, we could demonstrate that the protein levels of both Cdr2 and TRIM37 are stabilized under hypoxia, PHD as well as proteasome inhibition. Studies are now in progress to investigate the post- translational modification of Cdr2 and TRIM37 by PHD1.

To cite this abstract, please use the following information:
Acta Physiologica 2007; Volume 189, Supplement 653 :O08-7

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE